Fundraising Fox
🦊/Companies
Sign in

Regentis

Herzliya, IL · 1 known investors

Find your way into Regentis

Regentis Biomaterials develops regenerative medicine products for tissue repair, focused on orthopedic cartilage and bone treatments through its Gelrin degradable hydrogel platform. Its lead product, GelrinC, is a cell-free hydrogel implant for repairing articular knee cartilage injuries, CE-marked in Europe and in US clinical trials toward PMA approval.</parameter> <parameter name="founders">[]

BiotechHealthtechMedical Devices

Founders & leadership

GR
Galit ReskeExecutive
AG
Arie GordashnikovExecutive
OG
Ori GoninExecutive

Board

JDJeff Dykan
Jeff DykaninBoard directorPartner at SCP Vitalife Partners
EG
Ehud GellerBoard director
SA
Susan AlpertBoard director
PB
Pini Ben-ElazarBoard director
KV
Keith ValentineBoard director
EC
Efraim Cohen-AraziBoard director

Investors · 1

SCP Vitalife PartnersTel Aviv · $3M – $7M

Reported raises · per SEC filings

Form D private placements

$6.5M disclosed across 1 round · 2026

▶$6.5MraisedJun 2026 · 22 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Galit ReskeExecutive Officer
  • Arie GordashnikovExecutive Officer
  • Susan AlpertDirector
  • Pini Ben-ElazarDirector
  • Keith ValentineDirector
  • Efraim Cohen-AraziDirector
  • Jeff DykanDirector
  • Ori GonExecutive Officer
  • Ehud GellerExecutive Officer, Director
Offering amount
$6.5M
Amount sold
$6.5M
Sales commissions
$455K
Placement agents
ThinkEquity LLC
First sale
Jun 2026
Incorporated
Corporation, Israel
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
TradingView3 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.

Companies competing with Regentis for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Regentis Biomaterials (RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracksfinance.yahoo.com · Aug 2026Regentis Biomaterials (NYSE American: RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks - USA Todayusatoday.com · Aug 2026Regentis Biomaterials Raises $6.5 Million in Private Placement to Advance GelrinC Program - TipRanks.comtipranks.com · Jun 2026Regentis raises $6.5M in private placement | RGNT SEC Filing - Form 6-Kstocktitan.net · Jun 2026Regentis Biomaterials Jumps After Firm Scraps Public Offerts2.tech · Jun 2026Regentis Biomaterials Announces $10 Million Raised in Latest Round of Fundingprnewswire.com · May 2012

Frequently asked questions

What does Regentis do?
Regentis Biomaterials develops regenerative medicine products for tissue repair, focused on orthopedic cartilage and bone treatments through its Gelrin degradable hydrogel platform. Its lead product, GelrinC, is a cell-free hydrogel implant for repairing articular knee cartilage injuries, CE-marked in Europe and in US clinical trials toward PMA approval.</parameter> <parameter name="founders">[]
Who are Regentis's investors?
Regentis's investors include SCP Vitalife Partners.
How much funding has Regentis raised?
Regentis has disclosed $6.5M raised across 1 round.
Where is Regentis headquartered?
Regentis is headquartered in Herzliya, IL.